Whitehawk Therapeutics (WHWK) Assets (2010 - 2026)
Whitehawk Therapeutics (WHWK) posted quarterly Assets of $127.2 million for Q1 2026, down 45.63% year-over-year from $234.0 million in Q1 2025, and down 15.65% quarter-over-quarter from $150.8 million in Q4 2025.
Whitehawk Therapeutics (WHWK) Assets (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Assets for 17 consecutive years, with $127.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets fell 45.63% year-over-year to $127.2 million; the TTM figure through Mar 2026 stood at $127.2 million (down 45.63% YoY), while the FY2025 annual figure was $150.8 million, up 114.49% from the prior year.
- Assets slipped to $127.2 million in Q1 2026 per WHWK's latest filing, from $150.8 million in the prior quarter.
- Across five years, Assets topped out at $234.0 million in Q1 2025 and bottomed at $70.3 million in Q4 2024.
- Historically, Assets has averaged $145.4 million across 5 years, with a median of $142.3 million in 2022.
- Annual changes were most pronounced in 2022 — Assets jumped 245.76% — and 2024, when it tumbled 46.9%.
- Whitehawk Therapeutics' Assets stood at $184.2 million in 2022, then slipped by 28.12% to $132.4 million in 2023, then plunged by 46.9% to $70.3 million in 2024, then soared by 114.49% to $150.8 million in 2025, then declined by 15.65% to $127.2 million in 2026.
- Business Quant data shows WHWK's Assets at $127.2 million in Q1 2026, $150.8 million in Q4 2025, and $167.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | 193.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 193.99 Mn |
| Mar 31, 2026 | 127.23 Mn |
| Dec 31, 2025 | 150.83 Mn |
| Sep 30, 2025 | 167.02 Mn |
| Jun 30, 2025 | 180.82 Mn |
| Mar 31, 2025 | 234.00 Mn |
| Dec 31, 2024 | 70.32 Mn |
| Sep 30, 2024 | 85.70 Mn |
| Jun 30, 2024 | 101.62 Mn |
| Mar 31, 2024 | 111.07 Mn |
| Dec 31, 2023 | 132.42 Mn |
| Sep 30, 2023 | 139.66 Mn |
| Jun 30, 2023 | 151.23 Mn |
| Mar 31, 2023 | 170.65 Mn |
| Dec 31, 2022 | 184.24 Mn |
| Sep 30, 2022 | 194.10 Mn |
| Jun 30, 2022 | 128.64 Mn |
| Mar 31, 2022 | 142.32 Mn |
| Dec 31, 2021 | 157.91 Mn |
| Sep 30, 2021 | 168.77 Mn |